Kendra Q Crews, PA | |
126 S Anniston Ave, Sylacauga, AL 35150-2904 | |
(256) 249-6050 | |
(256) 249-6053 |
Full Name | Kendra Q Crews |
---|---|
Gender | Female |
Speciality | Physician Assistant - Medical |
Location | 126 S Anniston Ave, Sylacauga, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326484841 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | PA 886 (Alabama) | Secondary |
363AM0700X | Physician Assistant - Medical | PA 886 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kendra Q Crews, PA 126 S Anniston Ave, Sylacauga, AL 35150-2904 Ph: (256) 249-6050 | Kendra Q Crews, PA 126 S Anniston Ave, Sylacauga, AL 35150-2904 Ph: (256) 249-6050 |
News Archive
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
A new four-year, $3 million grant will enable Scripps Research scientists to advance compounds that may protect neurons in diseases caused by toxic protein accumulation, including Parkinson's, ALS, Alzheimer's and Creutzfeldt-Jakob disease.
Research by scientists at the University of Pittsburgh Cancer Institute has revealed how cancer cells hijack DNA repair pathways to prevent telomeres, the endcaps of chromosomes, from shortening, thus allowing the tumor to spread. The findings are published today in the journal Cell Reports.
Comprehensive Care Corporation, a leading behavioral health, substance abuse and psychotropic pharmacy management services provider for managed care companies throughout the U.S., is pleased to announce that its revenues for the nine months ended September 30, 2011 increased 212 percent to $54,039,000 compared to $17,344,000 for the same period in 2010.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced financial results for the first quarter of 2011.
› Verified 9 days ago